Phase 1/2 precision medicine study of the next-generation BRAF inhibitor PLX8394 Meeting Abstract
| Authors: | Janku, F.; Vaishampayan, U. N.; Khemka, V.; Bhatty, M.; Sherman, E. J.; Tao, J.; Whisenant, J. R.; Hong, D. S.; Bui, N.; Kummar, S.; Feun, L. G.; Parikh, A. R.; Zhang, C.; Michelson, G.; Martin, E.; Shellooe, R.; Severson, P.; Pelayo, M.; Karlin, D. A.; Sharma, S. |
| Abstract Title: | Phase 1/2 precision medicine study of the next-generation BRAF inhibitor PLX8394 |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 126s |
| Language: | English |
| ACCESSION: | WOS:000442916001362 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.2583 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 2583 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
